Zoliget 30mg plus 4mg Tablet
Zoliget 30mg plus 4mg Tablet (Pioglitazone+Glimepiride) combines two antihyperglycemic agents to improve glycemic control with type 2 diabetes: pioglitazone hydrochloride, a member of the thiazolidinedione class and glimepiride, a member of the sulfonylurea class. Chemically Zoliget 30mg plus 4mg Tablet is [(±)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2, 4-] thiazolidinedione monohydrochloride. Zoliget 30mg/4mg Tablet molecular formula is C19H20N2O3S.HCl. Zoliget 30mg plus 4mg Tablet is used in the management of type 2 diabetes particularly in overweight patients. Zoliget 30mg plus 4mg Tablet is used for managing non-insulin dependent diabetes. Zoliget 30mg plus 4mg Tablet: Midazolam: Administration of pioglitazone for 15 days followed by a single 7.5mg dose of midazolam syrup resulted in a 26% reduction in midazolam Cma x and AUC. K e t o c o n a z o l e : C o – a d m i n i s t r a t i o n o f p i o g l i t a z o n e f o r 7 d a y s w i t h k e t o c o n a z o l e 200mg administered twice daily resulted in a ratio of least square mean (90% CI) values for unchanged pioglitazone of 1.14 (1.06-1.23) for Cmax, 1.34 (1.26-1.41) for AUC and 1.87 (1.71-2.04) for Cmin .
This medicine is used in the management of type 2 diabetes particularly in overweight patients. This medication is used for managing non-insulin dependent diabetes
Side effect :
Some patients might experience visual disturbance and Respiratory infection. Please consult your doctor if you experience any of these symtpoms. Some patients might experience hypoglycemia and liver failure. Please consult your doctor if you experience any of these symptoms.
When not use :